Department of Cardiology and Cardiac Surgery, Cardiac Intensive Care Unit, Bambino Gesù Pediatric Hospital, IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.
Intensive Care Med. 2013 Sep;39(9):1594-601. doi: 10.1007/s00134-013-2985-x. Epub 2013 Jun 8.
Neurologic complications in neonates supported with extracorporeal membrane oxygenation (ECMO) are common and diminish their quality of life and survival. An understanding of factors associated with neurologic complications in neonatal ECMO is lacking. The goals of this study were to describe the epidemiology and factors associated with neurologic complications in neonatal ECMO.
Retrospective cohort study of neonates (age ≤30 days) supported with ECMO using data reported to the Extracorporeal Life Support Organization during 2005-2010.
Of 7,190 neonates supported with ECMO, 1,412 (20 %) had neurologic complications. Birth weight <3 kg [odds ratio (OR): 1.3; 95 % confidence intervals (CI): 1.1-1.5], gestational age (<34 weeks; OR 1.5, 95 % CI 1.1-2.0 and 34-36 weeks: OR 1.4, 95 % CI 1.1-1.7), need for cardiopulmonary resuscitation prior to ECMO (OR 1.7, 95 % CI 1.5-2.0), pre-ECMO blood pH ≤ 7.11 (OR 1.7, 95 % CI 1.4-2.1), pre-ECMO bicarbonate use (OR 1.3, 95 % CI 1.2-1.5), prior ECMO exposure (OR 2.4, 95 % CI 1.6-2.6), and use of veno-arterial ECMO (OR 1.7, 95 % CI 1.4-2.0) increased neurologic complications. Mortality was higher in patients with neurologic complications compared to those without (62 % vs. 36 %; p < 0.001).
Neurologic complications are common in neonatal ECMO and are associated with increased mortality. Patient factors, pre-ECMO severity of illness, and use of veno-arterial ECMO are associated with increased neurologic complications. Patient selection, early ECMO deployment, and refining ECMO management strategies for vulnerable populations could be targeted as areas for improvement in neonatal ECMO.
在接受体外膜肺氧合(ECMO)支持的新生儿中,神经系统并发症很常见,这降低了他们的生活质量和生存率。目前对新生儿 ECMO 中与神经系统并发症相关的因素知之甚少。本研究的目的是描述新生儿 ECMO 中神经系统并发症的流行病学和相关因素。
这是一项对 2005 年至 2010 年期间向体外生命支持组织报告的 ECMO 支持的新生儿(≤30 天龄)进行的回顾性队列研究。
在 7190 名接受 ECMO 支持的新生儿中,有 1412 名(20%)出现神经系统并发症。出生体重<3kg[比值比(OR):1.3;95%置信区间(CI):1.1-1.5]、胎龄<34 周(OR 1.5,95%CI 1.1-2.0)和 34-36 周(OR 1.4,95%CI 1.1-1.7)、在 ECMO 前需要心肺复苏(OR 1.7,95%CI 1.5-2.0)、ECMO 前血 pH 值≤7.11(OR 1.7,95%CI 1.4-2.1)、ECMO 前使用碳酸氢盐(OR 1.3,95%CI 1.2-1.5)、之前有 ECMO 暴露(OR 2.4,95%CI 1.6-2.6)和使用静脉-动脉 ECMO(OR 1.7,95%CI 1.4-2.0)增加了神经系统并发症的发生。与无神经系统并发症的患者相比,有神经系统并发症的患者死亡率更高(62%比 36%;p<0.001)。
新生儿 ECMO 中神经系统并发症很常见,与死亡率增加有关。患者因素、ECMO 前疾病严重程度和静脉-动脉 ECMO 的使用与神经系统并发症的增加相关。针对新生儿 ECMO 中的脆弱人群,改善患者选择、早期 ECMO 部署和完善 ECMO 管理策略可能是改进的重点。